Artivion, Inc. is a medical device company focused on developing solutions that address cardiac and vascular surgeonsâ challenges in treating patients with aortic diseases. The Company is engaged in the manufacturing, processing, and distribution of medical devices and implantable human tissues used in cardiac and vascular surgical procedures for patients with aortic disease. It has four major product families: aortic stent grafts, surgical sealants, On-X mechanical heart valves and related surgical products, and implantable cardiac and vascular human tissues. Its Medical Devices segment includes sales of aortic stent grafts, surgical sealants, On-X products, and other product revenues. Its Preservation Services segment includes services for the preservation of cardiac and vascular implantable human tissues. Aortic stent grafts include aortic arch stent grafts, abdominal stent grafts, and synthetic vascular grafts. Surgical sealants include its BioGlue Surgical Adhesive products.
äŒæ¥ã³ãŒãAORT
äŒç€ŸåArtivion Inc
äžå Žæ¥Feb 12, 1993
æé«çµå¶è²¬ä»»è
ãCEOãMackin (James Patrick)
åŸæ¥å¡æ°1600
蚌åžçš®é¡Ordinary Share
æ±ºç®ææ«Feb 12
æ¬ç€Ÿæåšå°1655 Roberts Boulevard N W
éœåžKENNESAW
蚌åžååŒæNASDAQ OMX NASDAQ Basic NYSE
åœUnited States of America
éµäŸ¿çªå·30144
é»è©±çªå·17704193355
ãŠã§ããµã€ãhttps://artivion.com/
äŒæ¥ã³ãŒãAORT
äžå Žæ¥Feb 12, 1993
æé«çµå¶è²¬ä»»è
ãCEOãMackin (James Patrick)
éå»5幎éã®é
åœéç·æ¯æé¡ã¯
0.00
ç±³ãã«ã§ããã

ããŒã¿ãªã